Mark Ragosa - Sep 1, 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Sep 1, 2024
Transactions value $
-$85,996
Form type
4
Date filed
9/4/2024, 08:51 PM
Previous filing
Jul 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +4.44K +22.37% 24.3K Sep 1, 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability -$60.4K -2.26K -9.3% $26.74 22.1K Sep 1, 2024 Direct
transaction KNSA Class A Ordinary Share Options Exercise +1.86K +8.44% 23.9K Sep 2, 2024 Direct F1
transaction KNSA Class A Ordinary Share Tax liability -$25.6K -956 -4% $26.74 23K Sep 2, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Award $0 +6.37K $0.00 6.37K Sep 1, 2024 Class A Ordinary Share 6.37K Direct F1, F2
transaction KNSA Share Option Award $0 +33.2K $0.00 33.2K Sep 1, 2024 Class A Ordinary Share 33.2K $26.74 Direct F3
transaction KNSA Restricted Share Unit Options Exercise $0 -2.69K -33.33% $0.00 5.39K Sep 1, 2024 Class A Ordinary Share 2.69K Direct F1, F4
transaction KNSA Restricted Share Unit Options Exercise $0 -1.75K -25% $0.00 5.25K Sep 1, 2024 Class A Ordinary Share 1.75K Direct F1, F5
transaction KNSA Restricted Share Unit Options Exercise $0 -1.86K -50% $0.00 1.86K Sep 2, 2024 Class A Ordinary Share 1.86K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
F3 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
F4 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
F6 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.